Your browser doesn't support javascript.
loading
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axis.
Williams, Anthony; Gutgesell, Lisa; de Wet, Larischa; Selman, Phillip; Dey, Arunangsu; Avineni, Mahati; Kapoor, Isha; Mendez, Megan; Brown, Ryan; Lamperis, Sophia; Blajszczak, Chuck; Bueter, Eric; Kregel, Steven; Vander Griend, Donald J; Szmulewitz, Russell Z.
Afiliação
  • Williams A; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Gutgesell L; Department of Pathology, University of Illinois at Chicago, 909 S Wolcott Avenue, Chicago, IL, 60612, USA.
  • de Wet L; Department of Pathology, University of Illinois at Chicago, 909 S Wolcott Avenue, Chicago, IL, 60612, USA.
  • Selman P; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Dey A; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Avineni M; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Kapoor I; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Mendez M; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Brown R; Department of Pathology, University of Illinois at Chicago, 909 S Wolcott Avenue, Chicago, IL, 60612, USA.
  • Lamperis S; Department of Medicine, Section of Hematology and Oncology, Northwestern University - Feinberg School of Medicine, 420 E Superior St, Chicago, IL, 60611, USA.
  • Blajszczak C; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Bueter E; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA; Committee on Cancer Biology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA.
  • Kregel S; Department of Cancer Biology, Loyola University - Cardinal Bernardin Cancer Center, 2160 S 1st Ave, Maywood, IL, 60153, USA.
  • Vander Griend DJ; Department of Pathology, University of Illinois at Chicago, 909 S Wolcott Avenue, Chicago, IL, 60612, USA.
  • Szmulewitz RZ; Department of Medicine, Section of Hematology & Oncology, The University of Chicago Medical Center, 5841 S Maryland Avenue, Chicago, IL, 60637, USA. Electronic address: rszmulew@medicine.bsd.uchicago.edu.
Cancer Lett ; 565: 216209, 2023 07 01.
Article em En | MEDLINE | ID: mdl-37169162

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Cancer Lett Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos